Interleukin-10 expression and cytotoxic-T-cell response in Epstein-Barr-virus-associated nasopharyngeal carcinoma
Open Access
- 29 July 1997
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 72 (3) , 398-402
- https://doi.org/10.1002/(sici)1097-0215(19970729)72:3<398::aid-ijc4>3.0.co;2-k
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Interleukin-10 production in malignant melanoma: Preferential detection of IL-10-secreting tumor cells in metastatic lesionsInternational Journal of Cancer, 1996
- Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's diseaseBlood, 1996
- BCL-2 Induction is Part of the Strategy of Epstein-Barr VirusLeukemia & Lymphoma, 1994
- Cytolytic (TIA-1+) Tumor Infiltrating Lymphocytes in B Cell Non-Hodgkin's LymphomasLeukemia & Lymphoma, 1993
- The two-signal model of lymphocyte activation twenty-one years laterImmunology Today, 1992
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991
- Expression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRF1Science, 1990
- Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virusNature, 1990
- Epstein–Barr virus latent membrane protein inhibits human epithelial cell differentiationNature, 1990
- Viral latency and transformation: The strategy of Epstein-Barr virusCell, 1989